A detailed history of Chelsea Counsel CO transactions in Pfizer Inc stock. As of the latest transaction made, Chelsea Counsel CO holds 27,800 shares of PFE stock, worth $693,332. This represents 0.45% of its overall portfolio holdings.

Number of Shares
27,800
Previous 27,880 0.29%
Holding current value
$693,332
Previous $802,000 3.87%
% of portfolio
0.45%
Previous 0.43%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Jun 14, 2024

SELL
$25.89 - $29.73 $2,071 - $2,378
-80 Reduced 0.29%
27,800 $771,000
Q4 2023

Feb 21, 2024

SELL
$26.13 - $33.94 $109,615 - $142,378
-4,195 Reduced 13.08%
27,880 $802,000
Q3 2023

Nov 22, 2023

SELL
$32.09 - $37.51 $170,077 - $198,803
-5,300 Reduced 14.18%
32,075 $1.06 Million
Q2 2023

Nov 22, 2023

SELL
$36.12 - $41.79 $187,824 - $217,308
-5,200 Reduced 12.21%
37,375 $1.37 Million
Q1 2023

May 19, 2023

SELL
$39.39 - $51.28 $51,207 - $66,664
-1,300 Reduced 2.96%
42,575 $1.74 Million
Q4 2022

Feb 23, 2023

SELL
$41.75 - $54.5 $148,630 - $194,020
-3,560 Reduced 7.51%
43,875 $2.25 Million
Q3 2022

Oct 31, 2022

SELL
$43.76 - $53.42 $672,459 - $820,905
-15,367 Reduced 24.47%
47,435 $2.08 Million
Q2 2022

Aug 01, 2022

SELL
$46.53 - $55.17 $455,389 - $539,948
-9,787 Reduced 13.48%
62,802 $3.29 Million
Q1 2022

May 24, 2022

SELL
$45.75 - $56.69 $1.18 Million - $1.46 Million
-25,807 Reduced 26.23%
72,589 $3.76 Million
Q4 2021

May 23, 2022

SELL
$41.32 - $61.25 $474,353 - $703,150
-11,480 Reduced 10.45%
98,396 $5.81 Million
Q3 2021

Feb 10, 2022

BUY
$39.25 - $50.42 $89,293 - $114,705
2,275 Added 2.11%
109,876 $4.73 Million
Q2 2021

Feb 10, 2022

BUY
$35.91 - $40.68 $79,720 - $90,309
2,220 Added 2.11%
107,601 $4.21 Million
Q1 2021

Feb 10, 2022

BUY
$33.49 - $37.77 $15,907 - $17,940
475 Added 0.45%
105,381 $3.82 Million
Q4 2020

Mar 08, 2022

BUY
$33.47 - $42.56 $1.79 Million - $2.27 Million
53,444 Added 103.85%
104,906 $3.86 Million
Q3 2020

May 06, 2022

BUY
$31.75 - $37.25 $698 - $819
22 Added 0.04%
51,462 $1.89 Million
Q2 2020

May 06, 2022

BUY
$30.12 - $36.54 $259,664 - $315,011
8,621 Added 20.13%
51,440 $1.68 Million
Q1 2020

Jun 12, 2020

SELL
$27.03 - $38.62 $13,515 - $19,310
-500 Reduced 1.15%
42,819 $1.4 Million
Q4 2019

Mar 23, 2020

SELL
$32.92 - $37.36 $3,292 - $3,736
-100 Reduced 0.23%
43,319 $1.7 Million
Q3 2019

Mar 23, 2020

SELL
$32.49 - $42.13 $16,245 - $21,065
-500 Reduced 1.14%
43,419 $0
Q2 2019

Dec 09, 2019

SELL
$36.98 - $41.52 $702 - $788
-19 Reduced 0.04%
43,919 $1.9 Million
Q1 2019

Dec 09, 2019

SELL
$37.5 - $41.2 $5,625 - $6,180
-150 Reduced 0.34%
43,938 $1.87 Million
Q2 2018

Oct 03, 2018

BUY
$32.98 - $35.16 $1.27 Million - $1.35 Million
38,446 Added 681.43%
44,088 $1.6 Million
Q4 2017

Jan 12, 2018

SELL
$33.26 - $35.29 $83,150 - $88,225
-2,500 Reduced 30.7%
5,642 $204,000
Q2 2017

Jan 22, 2018

BUY
N/A
8,142
8,142 $273,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $140B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Chelsea Counsel CO Portfolio

Follow Chelsea Counsel CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chelsea Counsel CO, based on Form 13F filings with the SEC.

News

Stay updated on Chelsea Counsel CO with notifications on news.